The trial tested two experimental eye drugs, Zenkuda and tabirafusp-ted, for treating wet age-related macular degeneration.

Megan Hall: If you’re over 60 and experiencing vision loss, it’s likely you have age-related macular degeneration, or AMD.

If you have wet age-related macular degeneration (wet AMD) or another disease of the retina, your doctor may recommend treatment with an anti-VEGF drug. VEGF, or vascular endothelial growth factor, is ...

The market for treatments of macular degeneration, cited as the leading cause of blindness in the elderly, is growing rapidly. Macular degeneration is a condition where abnormal blood vessels grow ...

Injection medications can save the vision of older people with macular degeneration, but the ongoing regimen is taxing. Now a preliminary study raises the possibility that some patients can safely be ...

An injection that helps to block the growth of abnormal blood vessels in the back of the eye in patients with wet age-related macular degeneration (AMD) is set to become available on the NHS in ...

A 39-year-old's heart paused for 15 seconds during a blood draw, and he needed chest compressions. He had fainted during a blood draw once before. A Man Came In for Swollen Feet and a Foot Wound, and ...

CHICAGO — The number of injections required for the successful treatment of neovascular age-related macular degeneration could be reduced considerably with experimental therapies, new research shows.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...